BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32740795)

  • 1. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
    De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
    Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
    Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
    Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
    J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease.
    Velazquez R; Tran A; Ishimwe E; Denner L; Dave N; Oddo S; Dineley KT
    Neurobiol Aging; 2017 Oct; 58():1-13. PubMed ID: 28688899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin.
    Khan MS; Ikram M; Park TJ; Kim MO
    Oxid Med Cell Longev; 2021; 2021():4051207. PubMed ID: 33728019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.
    Guerrero-Berroa E; Schmeidler J; Beeri MS
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1961-6. PubMed ID: 24529419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
    Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
    Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease.
    Li H; Yang S; Wu J; Ji L; Zhu L; Cao L; Huang J; Jiang Q; Wei J; Liu M; Mao K; Wei N; Xie W; Yang Z
    J Cell Biochem; 2018 Feb; 119(2):1616-1626. PubMed ID: 28771808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
    PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
    Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.
    De Sousa RAL; Improta-Caria AC
    Metab Brain Dis; 2022 Mar; 37(3):559-580. PubMed ID: 35075500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.
    Kapogiannis D; Boxer A; Schwartz JB; Abner EL; Biragyn A; Masharani U; Frassetto L; Petersen RC; Miller BL; Goetzl EJ
    FASEB J; 2015 Feb; 29(2):589-96. PubMed ID: 25342129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK
    J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.